SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-3.48 Cr | ₹27 Cr | ₹41 Cr | ₹55 Cr | ₹32 Cr |
What is the latest Cash Flow from Financing Activities ratio of SAKAR HEALTHCARE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-3.48 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹55 Cr |
| Mar2021 | ₹32 Cr |
How is Cash Flow from Financing Activities of SAKAR HEALTHCARE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-3.48 Cr | Negative | |
| Mar2024 | ₹27 Cr | -33.22 | |
| Mar2023 | ₹41 Cr | -24.76 | |
| Mar2022 | ₹55 Cr | 70.51 | |
| Mar2021 | ₹32 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,172.0 Cr | 6.7% | 28.8% | 118.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 6.7% |
28.8% |
118.7% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses